Sudbury company attracts $8M investment to support its leading-edge cancer treatment technology
A Sudbury-based company has received $8 million in private investment to support its work in cancer diagnostic technology.
Rna Diagnostics grew out of work done at Laurentian University and Health Sciences North Research Institute (HSNRI). Dr. Amadeo Parissenti, a scientist and LU professor, has developed technology that allows doctors to tell whether chemotherapy is having an impact on a patient's cancer.
"The RNA disruption assay (RDA), patented by Laurentian University and licensed to Rna Diagnostics in 2010, determines whether a patient is responding to cancer therapy, early during treatment," the company said in a news release Wednesday.
Using RDA, doctors can determine within five weeks of the start of treatment whether chemotherapy is working, allowing doctors to tailor the treatment according to the individual patient's response.
"This means that if a patient’s tumour is not responding to treatment, 80 per cent of ineffective doses and lost time can be avoided," the company said.
Rna Diagnostics has received $8 million in what's known as 'series A' financing from iGan Partners and BDC Capital. Series A financing is private funding that startup companies receive when their product or service shows enough promise to attract investment.
The discovery of RDA was made in 2007 by Parissenti and his research associate, Dr. Baoqing Guo, in their lab at HSNRI. It was patented by Laurentian University in 2010.
Rna Diagnostics’ laboratory is headquartered at HSNRI in Sudbury.
“The continued support of iGan Partners and our current investors, combined with the support of BDC Capital as a new investment partner, is exciting,” John Connolly, president and CEO of Rna Diagnostics, said in the news release.
“The closing of this series A financing will allow us to complete the pivotal validation trial (BREVITY) of the RNA Disruption Assay. BREVITY is currently recruiting patients at over 40 breast cancer centres in Europe and North America.”
Parissenti continues to study the cellular mechanisms involved in RNA disruption with Dr. Carita Lanner and Dr. Tom Kovala of the Northern Ontario School of Medicine in the hopes of finding additional tools to predict or monitor chemotherapy response and outcome in cancer patients.
“Laurentian University is proud to offer its congratulations to Dr. Parissenti and Rna Diagnostics Inc. on this incredible milestone, the investment will provide critical funding to complete the clinical trials and bring to market a technology that will improve cancer treatments worldwide while impacting positively on the quality of life of cancer patients,” Tammy Eger, Laurentian University’s vice-president, research, said in the release.
“A true northern innovation created by outstanding partnerships and collaboration.”
“This is an enormous, expensive problem for cancer centres. Typically, in solid tumors, only 30-40 per cent of patients receive a survival benefit from a given drug regimen,” Connolly added. “Patients with nonresponsive tumours (identified by the RDA) can therefore forgo the ineffective treatment and its side-effects and moved quickly to alternate treatments.”
CTVNews.ca Top Stories
How quietly promised law changes in the 2024 federal budget could impact your day-to-day life
The 2024 federal budget released last week includes numerous big spending promises that have garnered headlines. But, tucked into the 416-page document are also series of smaller items, such as promising to amend the law regarding infant formula and to force banks to label government rebates, that you may have missed.
Which foods have the most plastics? You may be surprised
'How much plastic will you have for dinner, sir? And you, ma'am?' While that may seem like a line from a satirical skit on Saturday Night Live, research is showing it's much too close to reality.
opinion I've been a criminal attorney for decades. Here's what I think about the case against Trump
Joey Jackson, a criminal defence attorney and a legal analyst for CNN, outlines what he thinks about the criminal case against Donald Trump in the 'hush money trial.'
$3.8M home in B.C.'s Okanagan has steel shell for extra wildfire protection
A home in B.C.'s Okanagan that features a weathering steel shell designed to provide some protection against wildfires has been listed for sale at $3.8 million.
Diver pinned under water by an alligator figured he had choice. Lose his arm or lose his life
An alligator attacked a diver on April 15 as he surfaced from his dive, nearly out of air. His tank emptied with the gator's jaws crushing the arm he put up in defence.
Psychologist becomes first person in Peru to die by euthanasia after fighting in court for years
A Peruvian psychologist who suffered from an incurable disease that weakened her muscles and had her confined to her bed for several years, died by euthanasia, her lawyer said Monday, becoming the first person in the country to obtain the right to die with medical assistance.
Mystery surrounds giant custom Canucks jerseys worn by Lions Gate Bridge statues
The giant stone statues guarding the Lions Gate Bridge have been dressed in custom Vancouver Canucks jerseys as the NHL playoffs get underway.
Celebrity designer sentenced to 18 months in prison for smuggling crocodile handbags
A leading fashion designer whose accessories were used by celebrities from Britney Spears to the cast of the 'Sex and the City' TV series was sentenced Monday to 18 months in prison after pleading guilty in Miami federal court on charges of smuggling crocodile handbags from her native Colombia.
Wildfire leads to evacuation order issued for northeast Alberta community
An evacuation order was issued on Monday afternoon for homes in the area of Cold Lake First Nation.